Infinity Piotroski F Score
INFI   USA Stock  USD 2.29 0.20 9.57% 
Infinity Piotroski F Score  Infinity Piotroski F Score 
At this time, it appears that Infinity Pharmaceuti's Piotroski F Score is Frail. Although some professional money managers and academia have recently criticized Piotroski FScore model, we still consider it an effective method of predicting the state of the financial strength of any organization that is not predisposed to accounting gimmicks and manipulations. Using this score on the criteria to originate an efficient longterm portfolio can help investors filter out the purely speculative stocks or equities playing fundamental games by manipulating their earnings..
3.0
Piotroski F Score  Frail
1  Current Return On Assets  Negative 
2  Change in Return on Assets  Decreased 
3  Cash Flow Return on Assets  Negative 
4  Current Quality of Earnings (accrual)  Decreasing 
5  Asset Turnover Growth  Increase 
6  Current Ratio Change  Increase 
7  Long Term Debt Over Assets Change  Higher Leverage 
8  Change In Outstending Shares  Decrease 
9  Change in Gross Margin  No Change 
Infinity Pharmaceuti Piotroski F Score Drivers
The critical factor to consider when applying the Piotroski F Score to Infinity Pharmaceuti is to make sure Infinity is not a subject of accounting manipulations and runs a healthy internal audit department. So, if Infinity Pharmaceuti's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back. Below are the main accounts that are used in the Piotroski F Score model. By analyzing the historical trends of the mains drivers, investors can determine if Infinity Pharmaceuti's financial numbers are properly reported.
Current Value  Last Year  Change From Last Year  10 Year Trend  

Weighted Average Shares  58 M  59.9 M 

 
Weighted Average Shares Diluted  58 M  59.9 M 

 
Net Cash Flow from Operations  (38.6 M)  (35.7 M) 

 
Total Assets  40.4 M  39.3 M 

 
Total Liabilities  61.7 M  62.3 M 

 
Current Assets  37 M  36 M 

 
Current Liabilities  16.8 M  11 M 

 
Total Debt  1.5 M  1.4 M 

 
Gross Margin  0.89  0.9 

 
Asset Turnover  0.0369  0.036 


Infinity Pharmaceuti F Score Driver Matrix
One of the toughest challenges investors face today is learning how to quickly synthesize historical financial statements and information provided by the company, SEC reporting, and various external parties in order to project the various growth rates. Understanding the correlation between Infinity Pharmaceuti's different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards Infinity Pharmaceuti in a muchoptimized way.
Click cells to compare fundamentals
About Infinity Pharmaceuti Piotroski F Score
FScore is one of many stock grading techniques developed by Joseph Piotroski, a professor of accounting at the Stanford University Graduate School of Business. It was published in 2002 under the paper titled Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers. Piotroski F Score is based on binary analysis strategy in which stocks are given one point for passing 9 very simple fundamental tests, and zero point otherwise. According to Mr. Piotroski's analysis, his FScore binary model can help to predict the performance of low pricetobook stocks.Book Value per Share  (0.39) 
Infinity Pharmaceuti Current Valuation Drivers
We derive many important indicators used in calculating different scores of Infinity Pharmaceuti from analyzing Infinity Pharmaceuti's financial statements. These drivers represent accounts that assess Infinity Pharmaceuti's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Infinity Pharmaceuti's important valuation drivers and their relationship over time.
2016  2017  2018  2019  2020  2021 (projected)  
Net Income Per Employee  (1.31 M)  (1.9 M)  (450.12 K)  (1.88 M)  (1.76 M)  (1.89 M)  
Revenue Per Employee  811.82 K  272.73 K  885.84 K  121.96 K  74.53 K  76.5 K  
Average Assets  176.34 M  79.52 M  56.84 M  62.83 M  48.01 M  49.27 M  
Earnings Before Interest Taxes and Depreciation Amortization EBITDA  (25.46 M)  (39.83 M)  (10.97 M)  (44.33 M)  (37.56 M)  (40.53 M)  
Earnings Before Interest Taxes and Depreciation Amortization USD  (25.46 M)  (39.83 M)  (10.97 M)  (44.33 M)  (37.56 M)  (40.53 M)  
Earnings before Tax  (30.1 M)  (42.55 M)  (11.25 M)  (47.11 M)  (40.49 M)  (43.69 M)  
Average Equity  91.26 M  58.45 M  50.8 M  23.83 M  (12.69 M)  (13.02 M)  
Enterprise Value  (12.86 M)  75.36 M  34.89 M  34.8 M  119.15 M  122.29 M  
Free Cash Flow  (152.88 M)  (36 M)  (4.71 M)  (43.86 M)  (35.78 M)  (38.61 M)  
Invested Capital  46.17 M  19.15 M  3.88 M  18.98 M  1.11 M  1.14 M  
Invested Capital Average  52.42 M  29 M  10.69 M  20.72 M  13.29 M  13.64 M  
Market Capitalization  67.14 M  102.94 M  67.1 M  54.75 M  136.12 M  139.7 M  
Tangible Asset Value  125.66 M  59.35 M  60.22 M  49.01 M  39.32 M  40.35 M  
Working Capital  77.8 M  46.79 M  52.1 M  34.88 M  24.97 M  25.63 M 
About Infinity Pharmaceuti Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Infinity Pharmaceuti's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Infinity Pharmaceuti using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Infinity Pharmaceuti based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI549, an orally administered clinicalstage immunooncology product candidate that inhibits the enzyme phosphoinositide3kinasegamma, which is in Phase 11b clinical trials for the treatment of triple negative breast cancer, solid tumors, and ovarian cancer. The company has strategic alliances with Intellikine, Inc. to discover, develop, and commercialize pharmaceutical products targeting the delta andor gamma isoforms of PI3K Verastem, Inc. to research, develop, commercialize, and manufacture duvelisib and products containing duvelisib and PellePharm, Inc. to develop and commercialize rights to its hedgehog inhibitor program, IPI926, a clinicalstage product candidate, as well as collaboration agreements with Arcus Biosciences, Inc., F. HoffmannLa Roche Ltd., and Bristol Myers Squibb Company. Infinity Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Cambridge, Massachusetts.
Infinity Pharmaceuti Investors Sentiment
The influence of Infinity Pharmaceuti's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decisionmaking process regarding taking a position in Infinity. The overall investor sentiment generally increases the direction of a stock movement in a oneyear investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.Infinity Pharmaceuti Implied Volatility  111.55 
Infinity Pharmaceuti's implied volatility exposes the market's sentiment of Infinity Pharmaceuti stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Infinity Pharmaceuti's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Infinity Pharmaceuti stock will not fluctuate a lot when Infinity Pharmaceuti's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Infinity Pharmaceuti in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Infinity Pharmaceuti's short interest history, or implied volatility extrapolated from Infinity Pharmaceuti options trading.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Infinity Pharmaceuti using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Please see Infinity Pharmaceuti Altman Z Score, Infinity Pharmaceuti Correlation, Infinity Pharmaceuti Valuation, as well as analyze Infinity Pharmaceuti Alpha and Beta and Infinity Pharmaceuti Hype Analysis. Note that the Infinity Pharmaceuti information on this page should be used as a complementary analysis to other Infinity Pharmaceuti's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Complementary Tools for Infinity Stock analysis
When running Infinity Pharmaceuti price analysis, check to measure Infinity Pharmaceuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Infinity Pharmaceuti is operating at the current time. Most of Infinity Pharmaceuti's value examination focuses on studying past and present price action to predict the probability of Infinity Pharmaceuti's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Infinity Pharmaceuti's price. Additionally, you may evaluate how the addition of Infinity Pharmaceuti to your portfolios can decrease your overall portfolio volatility.
Watchlist OptimizationOptimize watchlists to build efficient portfolio or rebalance existing positions based on meanvariance optimization algorithm  Go  
Portfolio CenterAll portfolio management and optimization tools to improve performance of your portfolios  Go  
Commodity Channel IndexUse Commodity Channel Index to analyze current equity momentum  Go  
ETF DirectoryFind actively traded Exchange Traded Funds (ETF) from around the world  Go  
Portfolio VolatilityCheck portfolio volatility and analyze historical return density to properly model market risk  Go  
Equity SearchSearch for activelly traded equities including funds and ETFs from over 30 global markets  Go  
Price TransformationUse Price Transformation models to analyze depth of different equity instruments across global markets  Go 
The market value of Infinity Pharmaceuti is measured differently than its book value, which is the value of Infinity that is recorded on the company's balance sheet. Investors also form their own opinion of Infinity Pharmaceuti's value that differs from its market value or its book value, called intrinsic value, which is Infinity Pharmaceuti's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Infinity Pharmaceuti's market value can be influenced by many factors that don't directly affect Infinity Pharmaceuti's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Infinity Pharmaceuti's value and its price as these two are different measures arrived at by different means. Investors typically determine Infinity Pharmaceuti value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Infinity Pharmaceuti's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.